These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 750187)

  • 21. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
    Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR
    Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
    Joshi JV; Naik VK; Joshi UM
    Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sensitive solid phase enzymeimmunoassay for norethisterone (norethindrone) in saliva and plasma.
    Turkes A; Dyas J; Read GF; Riad-Fahmy D
    Steroids; 1980 Apr; 35(4):445-57. PubMed ID: 6990558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low dose norethindrone acetate released through subdermal silastic implant on lipid metabolism in female rhesus monkeys.
    Yadava HS; Kochar J; Laumas KR
    Indian J Exp Biol; 1978 Feb; 16(2):160-1. PubMed ID: 98430
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic and endocrine studies in women using norethindrone acetate implant.
    Shahani SM; Kulkarni PP; Bhate PA; Patel KL
    Contraception; 1979 Feb; 19(2):135-44. PubMed ID: 428230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norethindrone antisera: anomalous cross-reactivities with use of 3H-tetrahydro-reduced norethindrone as radioligand.
    Watanabe H; Menzies JA; Jordan N; Loo JC
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):513-6. PubMed ID: 6635332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of norethisterone enanthate subdermal silastic implants on the ovary & uterus of adult rabbits.
    Srivastava UK; Mendiratta R
    Indian J Exp Biol; 1980 Nov; 18(11):1221-4. PubMed ID: 7216278
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subdermal progestin implant contraception.
    Darney PD
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of norethisterone from a bioabsorbable implant in female bonnet monkeys (Macaca radiata).
    Maitra A; Joshi UM; Kholkute SD; Munshi SR; Gupta GN; Tejuja S
    Contraception; 1980 Feb; 21(2):165-73. PubMed ID: 6768491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligands.
    Morris SE; Cameron EH
    J Steroid Biochem; 1975 Jul; 6(7):1145-50. PubMed ID: 1177442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of norethindrone (17 alpha-ethynyl-17 beta-hydroxy-4-estren-3-one) and ethynyl-estradiol (17 alpha-ethynyl-1,3,5, (10)-estratien-3, 17 beta-diol). Application to human plasma determination of norethindrone after oral administration of this steroid.
    Pasqualini JR; Castellet R; Portois MC; Hill JL; Kincl FA; Cortes-Prieto J
    Reproduccion; 1975; 2(3-4):197-205. PubMed ID: 1232004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the single steroid implant on the quantity and composition of milk in lactating women.
    Pal MN; Singh I; Jalnawalla SF
    J Obstet Gynaecol India; 1979 Jun; 29(3):552-6. PubMed ID: 12335916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II clinical study of implanted norethindrone pellets for longterm contraception in women. Program for Applied Research on Fertility Regulation.
    Adv Contracept; 1985 Dec; 1(4):295-304. PubMed ID: 3842220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of contraceptive seroids in breast milk and plasma of lactating women.
    Saxena BN; Shrimanker K; Grudzinskas JG
    Contraception; 1977 Dec; 16(6):605-13. PubMed ID: 606500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term regulation of male fertility by norethisterone enanthate 'epididymal' implants: effect on libido and fertility of rabbits.
    Srivastava UK
    Indian J Physiol Pharmacol; 1981; 25(2):158-62. PubMed ID: 7287137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluid-filled silastic capsules : a new approach to a more constant steroidal drug delivery system.
    Kumar D; Farooq A; Laumas KR
    Contraception; 1981 Mar; 23(3):261-8. PubMed ID: 7238045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.